Mundipharma Medical Company

Mundipharma is a global network of independent associated pharmaceutical companies, primarily owned by the Sackler family. The organization specializes in the development and commercialization of medicines across several core therapeutic areas, including pain management, oncology, respiratory diseases, and biosimilars. Historically known for its leadership in analgesic medications, Mundipharma has expanded its portfolio through strategic in-licensing agreements and partnerships, notably with companies like Celltrion for biosimilars. The company operates extensively across Europe, Asia-Pacific, Latin America, and the Middle East, maintaining a significant presence in both developed and emerging markets.